Skip to main content

Articles Tagged With:

  • Possible Link Between Acetaminophen Use During Pregnancy and Later ADHD Development

    A recent study showed that long-term maternal use of acetaminophen during pregnancy was associated substantially with ADHD, even after adjusting for indications of use, familial risk of ADHD, and other potential confounders. However, given that paternal use of acetaminophen also was associated with ADHD, the causal role of acetaminophen can be questioned.

  • Tips for Avoiding Huge False Claims Fines

    ASCs can run into regulatory trouble by simply creating a poorly structured business ownership agreement or by paying one owner physician more than another. Two health law experts highlighted common mistakes healthcare professionals make regarding the FCA, Anti-Kickback Statute, and Stark Law.

  • Stakes High Regarding False Claims Act Compliance

    Ambulatory surgery centers are vulnerable to False Claims Act violations because of their corporate structures and relationships.

  • Considering Systemic Treatment for Atopic Dermatitis

    A recent panel of eczema experts convened to provide advice about when clinicians should consider systemic treatment.

  • Cardiorespiratory Fitness and Mortality

    In both men and women in the United States, levels of cardiorespiratory fitness are inversely related to mortality. An encouraging epidemiologic study of women found that even brisk walking for about 30 minutes daily was associated with near maximal cardiovascular health benefits.

  • Searching for Answers on Knee Osteoarthritis

    Data consistently show that for knee osteoarthritis, weight loss is associated with symptomatic and functional improvement. The mechanism of this is incompletely understood, since weight loss has not been shown to affect the progressive degradation of cartilage typical of osteoarthritis.

  • New Pharmacologic Direction for Parkinson’s Disease

    Most clinicians are used to thinking about dopamine modulation when considering treatments for Parkinson’s disease. Unfortunately, none of the current treatments can be designated as disease-modifying, even though such treatment provides transient symptomatic relief.

  • Morphine in Dyspneic Acute Heart Failure

    Based on recent data, clinicians should avoid morphine use in acute heart failure patients.

  • CV Benefits of GLP-1RA Treatment in Type 2 Diabetes

    Among the sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist classes of pharmacotherapy, there appears to be much more similarity than not. Should clinicians consider these salubrious cardiovascular effects a class effect? That is, should all members of the class be anticipated to experience similarly favorable cardiovascular outcomes?

  • Revised Standards on Pain Assessment and Management Reflect Concerns About Opioid Epidemic

    As of Jan. 1, 2018, The Joint Commission will judge accredited hospitals according to newly revised standards for pain assessment and management. The standards are intended to address some of the unintended consequences of a nationwide focus on the under-treatment of pain, reflected in earlier versions. The revised standards push practitioners to offer alternatives to opioids when appropriate, and to engage patients in treatment planning for their pain so that realistic expectations are established.